D
Lifecore Biomedical, Inc. LFCR
$7.50 -$0.09-1.19% NASDAQ
Recommendation
Prev Close
$7.59
Volume
69,050
Avg Vol (90D)
189,752
Market Cap
$283.93M
Dividend & Yield
--
52-Week Range
$3.68 - $8.85
P/E (TTM)
--
EPS (TTM)
-$1.31
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Surprising Analyst 12-Month Target For OMFS
8/26/2025 - ETF Channel
Lifecore Biomedical (LFCR, $7.6) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 22, 2025
8/23/2025 - Tickeron - Stocks
Lifecore Biomedical (LFCR, $7.6) price moved above its 50-day Moving Average on August 22, 2025
8/23/2025 - Tickeron - Stocks
Boston Partners Invests $241,000 in Lifecore Biomedical, Inc. $LFCR
8/21/2025 - MarketBeat
Lifecore Biomedical (LFCR, $7.25) Moving Average Convergence Divergence (MACD) Histogram turned negative on August 19, 2025
8/20/2025 - Tickeron - Stocks
Does LifeCore (LFCR) Have a High Expected Value?
8/19/2025 - Insider Monkey
Lifecore Biomedical (LFCR) to Release Quarterly Earnings on Monday
8/19/2025 - MarketBeat
Lifecore Biomedical (NASDAQ:LFCR) Upgraded to Hold at Wall Street Zen
8/17/2025 - MarketBeat
Lifecore Biomedical (LFCR, $7.42) price exceeded its 50-day Moving Average on August 14, 2025
8/15/2025 - Tickeron - Technical Analysis
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. ...
8/15/2025 - GuruFocus
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
8/15/2025 - Globe Newswire
Lifecore Biomedical (LFCR, $7.63) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 12, 2025
8/13/2025 - Tickeron - Technical Analysis
Lifecore Biomedical (LFCR, $7.63) price moved above its 50-day Moving Average on August 12, 2025
8/13/2025 - Tickeron - Technical Analysis
Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations
8/11/2025 - Simply Wall St
Lifecore Biomedical Inc Reports Q4 Revenue of $36.4M, Exceeding Estimates; EPS Loss of $0. ...
8/9/2025 - GuruFocus
Lifecore Biomedical (LFCR) Gets a Hold from Barrington
8/8/2025 - TipRanks Financial Blog
Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript
8/8/2025 - SeekingAlpha
Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript
8/8/2025 - Seeking Alpha: Transcripts
The one-year returns have been decent for Lifecore Biomedical (NASDAQ:LFCR) shareholders despite underlying losses increasing
8/8/2025 - Simply Wall St
Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue ...
8/8/2025 - GuruFocus
Lifecore Biomedical (LFCR, $7.76) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 7, 2025
8/8/2025 - Tickeron - Stocks
Lifecore (LFCR) Q4 Revenue Beats 3%
8/8/2025 - Fool.com Headlines
Q4 2025 Lifecore Biomedical Inc Earnings Call Transcript
8/8/2025 - GuruFocus
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates
8/7/2025 - Zacks Investment Research
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides ...
8/7/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$128.87M
EBITDA (TTM)
-$2.01M
EBIT (TTM)
-$10.03M
Net Income (TTM)
-$38.72M
Balance Sheet
Total Assets (Q)
$239.34M
Total Debt (Q)
$130.82M
Total Liabilities (Q)
$191.91M
Book Value Per Share (Q)
$0.0361
Cash Flow
Cash from Operations (TTM)
-$206.00K
Cash from Investing (TTM)
-$6.42M
Cash from Financing (TTM)
$6.42M
Net Change in Cash (TTM)
-$197.00K
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Beginning of October (est)
Price History
Loading...
Beta
1.01
7-Day Total Return
1.76%
30-Day Total Return
-2.47%
60-Day Total Return
10.78%
90-Day Total Return
18.39%
Year to Date Total Return
12.61%
1-Year Total Return
18.30%
2-Year Total Return
-10.50%
3-Year Total Return
-26.40%
5-Year Total Return
-28.09%
52-week Low
Aug 29, 2024 - $3.68
52-week High
Jul 11, 2025 - $8.85
Valuation
Market Cap
$283.93M - Micro Cap
Enterprise Value
$452.58M
Price/Sales (TTM)
2.18
Price/Book (Q)
210.25
Dividends and Shares
Shares Outstanding
37.01
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.lifecore.com
Phone Number
(952) 368-4300
Address
3515 Lyman Boulevard
Chaska, MN 55318
Country
United States
Year Founded
1965
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the... more
NASDAQ 08/26/2025 4:00PM Eastern Quotes delayed